Genenta Science S.p.A (GNTA) Cash & Equivalents (2019 - 2025)
Genenta Science S.p.A (GNTA) recorded Cash & Equivalents of $6.43 million in the quarter ended Dec 31, 2025, up 31.4% from $4.9 million a year earlier.
Powered by 
Analysis
Genenta Science S.p.A (GNTA) Cash & Equivalents (2019 - 2025) Analysis & Trends
As of Dec 31, 2025, Genenta Science S.p.A reported Cash & Equivalents of $6.25 million, up 27.6% from the prior year.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -19.5% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Cash & Equivalents came in at $4.9 million in the year ended Dec 31, 2024 (+23.3%), $3.97 million in the year ended Dec 31, 2023 (-86.9%), $30.4 million in the year ended Dec 31, 2022 (-28.6%) and $42.6 million in the year ended Dec 31, 2021 (+131.0%).
- The figure for the quarter ended Dec 31, 2025 is the highest quarterly Cash & Equivalents since the quarter ended Jun 30, 2024.
- On a year-over-year basis, Cash & Equivalents rose in two of the last four quarters, with an average decline of 1.8%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 131.0% in the quarter ended Dec 31, 2021, against a decline of 86.9% in the quarter ended Dec 31, 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Genenta Science S.p.A | 17.57 Mn | 17.57 Mn | - | 6.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.43 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Dec 31, 2024 | 4.90 Mn |
| Jun 30, 2024 | 6.66 Mn |
| Dec 31, 2023 | 3.97 Mn |
| Jun 30, 2023 | 13.30 Mn |
| Dec 31, 2022 | 30.40 Mn |
| Jun 30, 2022 | 37.00 Mn |
| Dec 31, 2021 | 42.60 Mn |
| Dec 31, 2020 | 18.44 Mn |
| Dec 31, 2019 | 22.29 Mn |
API Access
Genenta Science S.p.A Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GNTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GNTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GNTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();